Stock Information
LENZ Therapeutics Inc (LENZ)
Ticker Symbol: LENZ
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $384.76 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -2.8017
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -28.75%
Latest News
-
LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade)
Fri, Mar 27, 2026 6:39 PM
-
Citigroup Maintains Buy on LENZ Therapeutics, Lowers Price Target to $26
Thu, Mar 26, 2026 11:42 AM
-
B of A Securities Maintains Buy on LENZ Therapeutics, Lowers Price Target to $29
Wed, Mar 25, 2026 9:21 AM
Key Financials
Financial data not available
